Pharma and Healthcare Social Media Marketing Market Surges with a Projected CAGR of 17.5% to Reach US$ 55,500.0 Million by 2032

The demand for pharmaceutical and healthcare social media marketing market is expected to increase significantly over the next decade. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 17.5% from 2022 to 2032, reaching a total value of approximately US$ 55,500.0 Million by 2032. When stakeholders in the pharmaceutical and healthcare industries reach out to potential customers through digital, social media platforms in today’s digital age, pharma and healthcare social media marketing is a topic that is extremely relevant.

Pharma and healthcare social media marketing is a topic that is extremely relevant in today’s digital age, when stakeholders in the pharmaceutical and healthcare industries are reaching out to potential customers via digital, social media platforms.

Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-403

The global market for pharma and healthcare social media marketing services is booming in the information age, as almost all the stakeholders in the pharma and healthcare industries are emerging in the world of social media to market their products, mainly because their potential customers are spending most of their time on social media.

Though social media tools are proving highly effective for the marketing of pharma and healthcare products in the world of customer-centric business, their use is still a matter of debate among end users.

Nevertheless, the overall growth of the global market for pharma and healthcare social media marketing services is expected to witness astonishing growth in the coming years, as a majority of businesses are taking their operations digitally.

Leading players in the market are increasing their focus on crafting creative marketing campaigns to help their customers gain a competitive advantage through more effective interaction and engagement with their target audience consistently.

Involvement of Regulatory Bodies may Restrict the Scope of Social Media Marketing for Pharma and Healthcare Companies

The pharma and healthcare sector is subjected to various rules and regulations regarding the marketing of medical and pharmaceutical products, and this scenario also follows in the planning of social media marketing strategies for these companies.

Governing bodies are modifying their traditional regulatory restrictions on the advertising of drugs and other marketing innovations in the pharma and healthcare industries.

Involvement of regulatory bodies in the global market for pharma and healthcare social media marketing is mainly in the areas of crafting and issuing guidelines in advertising of drugs and biologists through interactive media.

Various policies along with laws and regulations play an instrumental role in deciding the importance and effectiveness of social media in the marketing of pharma and healthcare products, though it restricts the scope of marketing campaigns.

For instance, the United States Food and Drug Administration (FDA) released new guidelines in January 2014, for the pharmaceuticals and healthcare industries defining the regulatory requirements vis-a-vis the marketing submissions for human and animal drugs across social media platforms.

Through its draft, the FDA also clarified various guidelines for content creators and marketers working in the pharmaceutical and healthcare marketing industry while working on the dissemination of branded information about drugs and biologics.

Pharma and Healthcare Social Media Marketing Market: Competitive Landscape

  • Digital Healthcare
  • Sermo
  • MomMD
  • Student Doctors Network
  • QuantiaMD
  • Doximity
  • Healthcare and Medical Software
  • Orthomind
  • WeMedUp
  • Medical Apps
  • DoctorsHangout
  • Nurse Zone
  • All Nurses
  • Medical Doctors
  • Ozmosis

Other pharma and healthcare companies that are highly engaged in social media marketing include Novartis, Johnson & Johnson, Pfizer, Inc., Novo Nordisk, and Bayer AG.

Seize this Opportunity: Buy Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/403

Key Segments Covered in the Pharma and Healthcare Social Media Marketing Industry Analysis

By Social Media Platform:

  • YouTube
  • Twitter
  • Instagram
  • Facebook

By End User:

  • Healthcare Professionals
  • Hospitals
  • Biotechnology Companies
  • Patients/Consumers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Palliative Care Market Envisions US$ 28,518.5 Million Valuation by 2032 | Future Market Insights,Inc.

In 2022, the global Palliative Care Market is expected to be worth US$ 13,087.9 million. Palliative care is given to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD), and others, and it includes symptomatic relief for nausea and vomiting, diarrhoea, pain and anxiety, loss of appetite, and other symptoms. The overall demand for Palliative Care is expected to grow at a 7.3% CAGR between 2022 and 2032, reaching approximately US$ 28,518.5 million by 2032.World Health Organization (WHO) defines palliative care as an approach to improve the quality of life of a patients and their families who are facing difficulties related to the fatal illness by providing a treatment for relieving the symptoms of an underlying disease/disorder. Whereas, Hospice care is a specific type of palliative care procedure to help the terminally ill patients to make their final months/days of life soothing and less painful. Palliative care is provided to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD) and others, providing symptomatic relief for nausea & vomiting, diarrhea, pain & anxiety, loss of appetite and many more. International Association for Hospice and Palliative Care (IAHPC) have listed 32 essential medicines for the hospice and palliative care, including analgesics, antiemetic etc. Palliative care concentrates on furnishing patients with the alleviation of the side effects, stress, and worry of a genuine sickness irrespective of the diagnosis. The objective is to enhance personal satisfaction for both the patient and the family. Palliative care is given by a group of doctors, specialists, medical caretakers, and different masters, who cooperate with a patient’s different specialists to give an additional layer of help. It is fitting at any age and at any phase in a genuine ailment, and can be furnished alongside remedial treatment.Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5522

Palliative Care Market: Overview

The global market for palliative care is expected to flourish over the forecast period of 2017-2027 due to increasing awareness about physical, social and psychological, needs of patients with life-threatening diseases and their families. Majority of people receiving hospice care are the cancer patients, according to WHO.

Palliative Care Market: Region-wise Overview

Geographically, the global market for palliative care is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to take greater share in global palliative care market because of good reimbursement and insurance coverage for palliative care services. Countries like Mexico in the Latin American region have more number palliative care centers for children.

Some of the key players and healthcare service providers in global palliative care market are: Center to Advance Palliative Care (CAPC), UCLA Health, National Hospice and Palliative Care Organization, VITAS Healthcare, CHI Franciscan, University of Washington (UW Medical Center & UW Medicine), Seymour Health, KEHPCA (Kenya Hospices and Palliative Care Association) & others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Unlock exclusive insights with our expert analysts :
 https://www.futuremarketinsights.com/ask-question/rep-gb-5522

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Palliative Care Market: Segmentation

The global palliative care market has been classified on the basis of service type, end user and geography.

Based on service type, the global palliative care market is divided into following:

  • Private residence care
  • Hospice inpatient care
  • Hospital inpatient care
  • Nursing home and residential facility care
  • Others

Based on end user type, the global palliative care market is divided into following:

  • Hospitals
  • Home Care Settings
  • Palliative Care Centers
  • Long Term Care Centers & Rehabilitation Centers

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Insights Designed for You: Customize Your Exclusive Report Today :
https://www.futuremarketinsights.com/customization-available/rep-gb-5522

Key Segments Covered in the Palliative Care Industry Analysis

By Service Type:

  • Private Residence Care
  • Hospice Inpatient Care
  • Hospital Inpatient Care
  • Nursing Home and Residential Facility Care
  • Others

By End User:

  • Hospitals
  • Home Care Settings
  • Palliative Care Centers
  • Long-Term Care Centers & Rehabilitation Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Projected Growth: Calcium Sulfate Industry Set to Reach US$ 338.54 Billion by 2033

In 2023, the calcium sulfate market is expected to be worth US$ 266.84 billion, and by 2033, It is expected to reach US$ 338.54 billion. Calcium sulfate sales are expected to grow at a CAGR of 4.1% over the forecast period.

The melting point of calcium sulfate is 1,400°C. It is a white, odorless powder. In nature, it can be found as both a hydrated and anhydrous powder. Calcium sulfate can be found in a variety of forms, including selenite, satin, light spar, terra alba, and satinite. When calcium sulfate is heated, a considerable amount of water molecules are released, resulting in plaster of Paris (POP).

POP hardens into a mass when mixed with water and can be used to manufacture plaster casts, wall plasters, and other items. Furthermore, calcium sulfate is used as a drying agent in laboratories, a coating agent in the paper industry, a color pigment in paintings, and a soil conditioner in agriculture.

The rise in the use of calcium sulfate in construction products such as rapid setting cement, plaster of Paris, and wall plasters is the primary factor driving the growth of the worldwide calcium sulfate market. It is also commonly used in dental offices as a tool for generating casts or dental imprints, which aids market growth.

Access Your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4038

The rising pulp and paper industry is driving demand for calcium sulfate, which is used as a surface sizing agent and a pigment to generate coated paper with high brightness and whiteness. Furthermore, the market is expected to expand at a quicker rate due to an increasing demand for calcium sulfate as a calcium supplement that is necessary for cell and bone formation.

The market is also expected to grow due to an increase in the use of calcium sulfate as a desiccant and an inactive component in pharmaceuticals. The rapidly expanding applications across numerous end-use sectors, as well as rising demand from emerging nations, are expected to provide potential development chances for market expansion.

Given the increasing demand for calcium sulfate in emerging markets such as China and India, the Asia-Pacific region held the largest market share for calcium sulfate in 2022 and is expected to maintain that position in the future. China is expected to maintain its dominance in the calcium sulfate market over the forecast period. This is due to the country’s expanding building industry. The demand for calcium sulfate as an additive, reducing agent, and drying agent is expected to expand over the anticipated period, and this is proving to be a key driver of calcium sulfate market expansion in this region.

KEY TAKEAWAYS

  • The market in the United States has grown significantly in 2022 holding a 10.7% share of the global market.
  • The market in China is expected to grow at a CAGR of 4.1% over the forecast period.
  • The market in the United Kingdom is anticipated to grow at a CAGR of 2.7% through 2033.
  • With a CAGR of 5.8% over the forecast period, India is predicted to grow rapidly in the market.
  • Germany accounted for 3.8% of the global market in 2022.

Get Instant Access to the Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-4038

COMPETITIVE LANDSCAPE

The top manufacturers of the calcium sulfate market are USG Corporation, Solvay SA, Honeywell International Inc., Beijing New Building Materials PLC, Penta Manufacturing Company, Boral Limited, Compagnie de Saint-Gobain SA, YOSHINO GYPSUM CO., LTD., JONOUB GYPSUM, PABCO Building Products, LLC, Celtic Chemicals Limited, Georgia-Pacific LLC, and among others.

To meet the rising demand from several end-use sectors, such as construction, food and beverage, and pharmaceuticals, manufacturers in the calcium sulfate market are concentrating on creating high-quality goods. In order to lessen their influence on the environment and adhere to rules, they are also implementing sustainable production techniques. Also, to reach new markets and boost their market share, firms are extending their global reach through strategic alliances and acquisitions.

RECENT DEVELOPMENTS

  • In July 2022, Alberta-based CGC Inc., a Canadian unit of USG Corporation, aims to open a brand-new, slashing wallboard manufacturing facility in Wheatland County. This investment could further enable CGC to provide even greater service to its devoted customers in Alberta and the West, and it also demonstrates CGC’s commitment to the Canadian market.
  • In order to reduce the cost of building construction and boost productivity and speed of implementation, Jonoub Gypsum Co. started manufacturing its new product, “Mixed soil and gypsum (Soil Gypsum)” in July 2018.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Non-GMO Food Products Market Sets Sail for US$ 144,322 Million by 2031 A Global Perspective on Smart Labels Transparent Food Producers

Newly released data from the non-GMO food products market analyzed by FMI estimates that the non-GMO food products market enjoys a growth rate of 10.4% at present. The market is expected to witness a prominent growth rate of a CAGR of 13.2% to reach the value of US$ 144,322 Million in 2031.

The introduction of smart labels, which provide quick access to product-specific information, is another element fueling the expansion of transparent, non-GMO food producers across international borders. The market is expected to reach US$ 3.4 billion in value by the end of 2031.

Boost Your Understanding of the Market To discover more about the rapidly expanding non-GMO food product market, send an inquiry for a sample report to:
https://www.futuremarketinsights.com/reports/sample/rep-gb-11088

The demand from consumers for non-GMO food items will increase as a result of dietary trends including healthy eating and choosing natural food products, among other developments. An increase in health-related problems and growing knowledge of the negative effects of consuming genetically modified foods are the driving forces behind this transformation.

Key Takeaways of non-GMO Food Product Market Study

  • Grains and Cereals will dominate market demand with a multiplying growth rate of 22% through the end of 2029.
  • Bakery & Confectionary products present gainful opportunities with a stupendous growth rate of 19% during the forecast period.
  • Dairy products is another segment that will register a CAGR of 16% from 2019 to 2029.
  • Indirect distribution channels will maintain share-wide and growth-wise dominance throughout the forecast period.
  • North America and Latin America collectively account for more than half of total market value. This can be attributed to the early adopting nature of North American countries and rising millennial population in Latin America.

Consumer Preferences Shape Growth Trajectory

Increase in purchase potential and decrease in production costs is creating remunerative synergy in the market. This is fueled by advancements in packaging and labelling along with proactive consumer participation. Major players are investing in developing consumer communities that support long-term revenue generation.

The non-GMO food products industry is dependent on consumer awareness and prevalence of plant-based and vegan diets that require daily consumption of food products manufactured from non-genetically modified organisms.

Who’s Wining?

Competitive landscape in non-GMO food products industry is fragmented with the presence of multinationals, niche-manufacturers, and SMEs. Major players that shape the global non-GMO food products industry are Cargill, Inc., Associated British Foods Plc, General Mills Inc., Kraft Heinz, Archer Daniels Midland Company, Danone, Nestle S.A., The Hain Celestial Group Inc. Key players in the market are forging strategic partnerships that ensure sustained revenue prospects.

Spend money on market insights for non-GMO food products. Get It Now to Keep Up with Industry Trends and Rivals:
https://www.futuremarketinsights.com/checkout/11088

Market Segments Covered in Non-GMO food products Industry Analysis

By Nature :

  • Organic
  • Conventional

By Product :

  • Grain and Cereals
    • Wheat
    • Soya
    • Corn
    • Others
  • Bakery and Confectionery
    • Bread
    • Pastry
    • Candy
    • Others
  • Beverages
    • Alcoholic Beverages
    • Non-Alcoholic Beverages
  • Dairy Products
    • Yogurt
    • Cheese
    • Ice cream
    • Others
  • Infant Food
  • Condiment, Dressing, & Oil
    • Vegetable Oils
    • Jam, Jellies
    • Syrups
  • Others (Spices, soups, etc.)

By Distribution Channel :

  • Direct Sales/B2B
  • Indirect Sales/B2C
    • Supermarket/Hypermarket
    • Wholesaler
    • Online Retail
    • Specialty Stores
    • Other Retail Format

Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

All of the information is available to you! To obtain the complete report, contact one of our analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-11088

Key Questions Answered in the Report

How much is the Non-GMO food products market currently worth?

Non-GMO food products industry size is worth more than US$ 41,510 Mn.

At what CAGR is the market expected to grow?

Non-GMO food products consumption is expected to grow at a CAGR of around 13.2% during the period 2021-2031.

How was the performance in the last five years?

In terms of revenue non-GMO food products grew at a CAGR of around 10.4% during 2016-2020

What are the key trends boosting Non-GMO food product sales?

Non-GMO food products are gaining traction due to concerns over the effect of genetically modified foods on health, advanced technologies, shifting consumers’ preference towards healthy food products are the latest trends of non-GMO food products being observed in the market.

How are market players reacting to the new developments in the market?

Market companies are choosing to aim at research and development, consolidation of distribution channel in emerging countries, new product introductions to stay a noticeable player in the global market.

Which are the major countries driving demand for the Non-GMO food products Market?

The US, Russia, UK, China, Brazil, Germany, India are the major countries driving demand for non-GMO food products.

At what level does the report reflect pricing analysis?

The report presents a detailed cost analysis of non-GMO food products based on products i.e. grain and cereals, bakery & confectionery, beverages, dairy products, infant food, condiment, dressing, & oil, and others.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

 Contact Us:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Blood Coagulation Analyzers Industry Poised to Transform Medical Care, Projected at US$ 5,680.7 Million by 2033 According to FMI

The blood coagulation analyzers industry refers to the global industry that produces and sells devices used to analyze blood clotting or coagulation processes. These analyzers are essential in diagnosing and monitoring various bleeding disorders, thrombotic events, and coagulation abnormalities.

Key players in the blood coagulation analyzers industry develop and distribute devices that measure the clotting time, clotting factors, and other parameters related to coagulation. These analyzers are primarily used in hospitals, clinics, diagnostic laboratories, and research institutions.

Get your PDF Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-4524

By 2023, the market for blood coagulation analyzers is projected to be worth US$ 3,038.9 million, and by 2033, it is anticipated to be worth US$ 5,680.7 million. Blood coagulation analyzer sales are predicted to increase at a CAGR of 6.5% over the course of the projection period.

The market for blood coagulation analyzers has been experiencing steady growth in recent years due to several factors. These include:

  • Increasing prevalence of bleeding disorders and thrombotic events: The rising incidence of conditions such as hemophilia, von Willebrand disease, and deep vein thrombosis has created a demand for coagulation analyzers for accurate diagnosis and management.
  • Aging population: As the global population continues to age, the prevalence of coagulation disorders and related conditions increases. This drives the need for blood coagulation analyzers to monitor and manage these conditions effectively.
  • Technological advancements: Advances in technology have led to the development of more efficient and accurate coagulation analyzers. These devices provide faster results, improved precision, and enhanced automation, leading to increased adoption in healthcare settings.
  • Growing awareness and healthcare expenditure: Increased awareness about the importance of early diagnosis and management of bleeding and clotting disorders, along with higher healthcare spending in many countries, has contributed to the growth of the blood coagulation analyzers industry.
  • Expansion of point-of-care testing: Point-of-care testing (POCT) has gained popularity in recent years due to its convenience and rapid results. Blood coagulation analyzers suitable for POCT settings are being developed and adopted, further driving market growth.

Blood coagulation analyzers industry: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Blood coagulation analyzers industry. Competitive information detailed in the Blood coagulation analyzers industry report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Blood coagulation analyzers industry report.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-4524

Key players covered in the report include:

  • Diagnostica Stago
  • NIHON KOHDEN CORPORATION
  • Helena Laboratories
  • Instrumentation Laboratory
  • International Technidyne Corporation
  • Roche Diagnostics
  • Danaher Corporation Abbott Laboratories

Important Questions Answered in the Blood coagulation analyzers industry Report

  • Which end user remains the top revenue contributor in different regional markets?
  • At what rate has the global Blood coagulation analyzers industry been expanding during the forecast period?
  • How will the global Blood coagulation analyzers industry look like by the end of the forecast period?
  • What innovative strategies are adopted by Blood coagulation analyzers industry players to stay ahead of the pack?
  • What are the restraints affecting the growth of the global Blood coagulation analyzers industry?

For More Report Customization, connect with us at! https://www.futuremarketinsights.com/customization-available/rep-gb-4524

Blood coagulation analyzers industry: Segmentation

Valuable information covered in the FMI’s Blood coagulation analyzers industry report has been segregated into key segments and sub-segments.

By Product:

  • Systems
  • Automated Systems
  • Semi-Automated Systems
  • Manual Systems
  • Reagents
  • Accessories

By Technology:

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology

By Test Type:

  • Prothrombin Time Testing
  • Fibrinogen Testing
  • Activated Clotting Time Testing
  • Activated Partial Thromboplastin Time Testing
  • D-Dimer Testing
  • Platelet Function Tests
  • Anti-Factor Xa Tests
  • Heparin & Protamine Dose Response Tests for ACT

By Distribution Channels:

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Brain Tumors Treatment Industry is Expanding, Driven by the Increased Availability of Specific Drugs, Set to Surpass US$ 6,228.2 Million By 2033

The brain tumor treatment industry worldwide is anticipated to reach a market value of US$ 3,114.2 million in 2023 and US$ 6,228.2 million by 2033, registering a CAGR of 7.2% during the forecast period. Key factors that are anticipated to foster the expansion of the brain tumour diagnosis market globally include the rising prevalence of such malignancy and the expanding elderly population. Treatment for brain tumours saw a CAGR of 4.7% over the preceding ten years.

Brain tumor refers to an abnormal mass of tissue wherein the brain cells magnify and expand in an unbridled manner. Primary brain tumor makes up the majority of brain tumor incidences. For example, as per the study released by a Cancer Journal for Clinicians, in the year 2021, approximately 83,570 people were identified with brain tumors in the United States, from which primary brain tumors formed 70.3% of the cases. The rise in brain tumors can be attributed to a surging aging population, an accelerating rate of smokers, and increasing exposure to electromagnetic radiation.

Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-1302

Brain tumor contributes 1-2% of all cancer types. Moreover, the mortality rate for people suffering from this cancer is also high. Most of these cases are observed in North America and Asia Pacific. National Brain Tumor Society (NBTS) declared that it is offering funding worth US$ 1,00,000 to contribute toward the study conducted on the efficiency of CT-179, which is a novel drug candidate. This drug is expected to be a potential treatment for glioblastoma.

A growing pool of patients and a surging focus of key players toward research and development to launch advanced drugs with clinical advantages for the management of this condition is expected to fuel market growth.

Top Highlights from the FMI’s Analysis of the Brain tumor treatment industry:

  • North America’s brain tumor treatment industry has a massive stake in the market. In 2022, the region represented 34.2% market share, suggesting significant investment opportunities in the market.
  • Europe garnered a 24.2% value share in 2022 and is expected to observe an expansion in market size in the upcoming years. Surging investments in the healthcare sector and increasing cases of brain tumors are expected to attract key players in this market.
  • The United States’ stake in the market is significantly high, i.e., 30.2%. Increasing medical tourism to seek top-quality healthcare services is projected to accelerate market growth.
  • Germany held 5.1% of the market in 2022. The prominence of the country in Europe and the world over and the widespread prevalence of cancer cases have opened significant revenue-generating prospects for market participants.
  • China is expected to be the robust market for brain tumor treatment in the forecast period, luring manufacturers to expand and build capacities in the country.
  • India is another key market for brain tumor treatment in terms of CAGR. Over the forecast period, India is expected to observe a CAGR of 7.2%.
  • The United Kingdom registered a CAGR of 5.1% over the forecast period.
  • Based on product, the temozolomide segment captured 25.6% of the market share in 2022.
  • Under the category of end users, the hospital pharmacies segment gained a massive share of 44.8% in 2022.

Don’t Hesitate To Get In Touch With Our Analyst To Resolve Your Inquiries! https://www.futuremarketinsights.com/ask-question/rep-gb-1302

Key Developments in the Market:

  • To maximize the administration of certain psychedelic drug candidates, Nextage Therapeutics and MindMed signed an MOU in April 2021 that ascertains deployment of the patented Brain Targeting Liposome System (BTLS) delivery technology.
  • GenMarkDiagnostics and Roche came into a definitive merger agreement in March 2021 for Roche to entirely obtain GenMark for a value of US$ 24.05 per share in an all-cash transaction.

Key Companies Profiled:

  • Genentech USA
  • Bristol Myers Squibb
  • Hoffmann- La Roche
  • AstraZeneca Plc.
  • Pfizer Inc.
  • Novartis AG
  • Antisense Pharma
  • Merck & Co
  • MacLeod’s Pharmaceutical Limited
  • Mankind Pharma
  • Siemens Healthineers AG
  • Dr. Reddy’s Laboratories Ltd.

Ignite Innovation with Customization: Uncover the Possibilities in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-1302

Key Segments Covered in the Brain Tumor Treatment Industry Analysis:

By Product:

  • Temozolomide
  • Carmustine
  • Cisplatin
  • Bevacizumab
  • Geftinib
  • Erlotinib

By End User:

  • Hospital Pharmacies
  • Ambulatory Surgical Centers
  • Individual Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Passwordless Authentication Market: Key Trends and Insights on the Path to US$ 55,679.4 Million in 2032

The passwordless authentication market is expected to experience substantial growth in the coming years, with a projected CAGR of 15.3% from 2022 to 2032. This growth is anticipated to culminate in a total market value of approximately US$ 55,679.4 million by 2032. The global passwordless authentication market was be worth US$13,450.4 million in 2022.

Passwordless authentication refers to a method of logging into an application or service without having to enter a password. Instead, users can use biometric authentication, one-time codes sent to their phone or email, or security keys to gain access. The market for passwordless authentication solutions is growing rapidly as consumers and businesses seek more secure and convenient ways of accessing their accounts and data. Some of the key players in the market include Microsoft, Google, Apple, Amazon, and many startups that specialize in biometric authentication and security solutions.

Request for a Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13299

Sometimes a username is still needed for authentication. A few distinct biological traits of an individual are used by the passwordless authentication security method to confirm authenticity. The development of passwordless authentication solutions is being fueled by important considerations like better security and simple ways to access data from anywhere. The entire market for passwordless authentication is anticipated to reach about US$ 55,679.4 million by 2032, growing at a CAGR of 15.3% between 2022 and 2032.

What is Driving Demand for Passwordless Authentication? 

There is an increase in penetration of smartphones and other consumer electronic devices, demanding for access to end-user accounts and logins. Growing adoption of passwordless authentication for an additional layer of security beyond passwords is another factor driving the growth of passwordless authentication market. 

Further, advanced technologies such as internet of things (IoT) and artificial intelligence in devices such as smartphones and tablets among others are factors, driving the growth of passwordless authentication solutions. There are companies, who are adopting the use of fingerprint authentication and smartcards in their offices, which is further propelling the sales of passwordless authentication systems. 

Security points like fingerprint sensors and smartcards are making a way for a smooth flow of data between point and allowing for a seamless experience. Enterprises are making use of facial recognition, voice analysis and iris recognition to authenticate and verify its employees. Furthermore, the global rise in applications of fingerprint recognition and facial recognition in consumer electronics is expected to propel the passwordless authentication demand.          

Rise in Applications of Passwordless Authentication in Banking Sector:

There are roughly 80% of hacking-related breaches because of weak and reused passwords. More than 90% users reuse passwords across work and personal accounts. This is the reason, why banking industry is moving towards implementation of passwordless authentication for an additional layer of security of their customer’s accounts. 

Human errors are always referred as a security hole, which cannot be fixed by IT team. There are several ways that IT can minimize the risk, pro security professional are heavily focusing on the same. The particularly weak link is authentication, so authentication system in banking sector are adopting, especially as cloud services multiply and there is an increase in danger from weak or stolen passwords. 

Thus, rise in applications of passwordless authentication in banking sector is augmenting the growth of passwordless authentication solutions globally.   

Major Key Players:

  • Fujitsu Ltd.
  • NEC Corporation
  • Accu-Time Systems Inc.
  • EyeVerify, Inc.
  • Crossmatch Technologies
  • M2SYS Technology
  • Thales Group
  • Safran
  • Dermalog Identification Systems GmbH
  • East Shore Technologies, Inc. and others.

Seize this Opportunity: Buy Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/13299

Passwordless Authentication Industry Segmentation:

By Solution:

  • Passwordless Authentication Software
  • Services
    • Professional Services
    • Managed Services

By Authentication Type:

  • Single-factor Authentication
  • Multi-factor Authentication

By End-use Industry:

  • BFSI
  • Consumer Electronics
  • Logistics
  • Government
  • Aerospace & Defense
  • Healthcare
  • Retail
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Non-GMO Food Products Market Projected to Reach US$ 144,322 Million by 2031 Europe, USA, and Global

Newly released data from the non-GMO food products market analyzed by FMI estimates that the non-GMO food products industry enjoys a growth rate of 10.4% at present. The market is expected to witness a prominent growth rate of a CAGR of 13.2% to reach the value of US$ 144,322 Mn in 2031.

The introduction of smart labels, which provide quick access to product-specific information, is another element fueling the expansion of transparent, non-GMO food producers across international borders. The market is expected to reach US$ 3.4 billion in value by the end of 2031.

Boost Your Understanding of the Market To discover more about the rapidly expanding non-GMO food product market, send an inquiry for a sample report to:
https://www.futuremarketinsights.com/reports/sample/rep-gb-11088

The demand from consumers for non-GMO food items will increase as a result of dietary trends including healthy eating and choosing natural food products, among other developments. An increase in health-related problems and growing knowledge of the negative effects of consuming genetically modified foods are the driving forces behind this transformation.

Key Takeaways of non-GMO Food Product Market Study

  • Grains and Cereals will dominate market demand with a multiplying growth rate of 22% through the end of 2029.
  • Bakery & Confectionary products present gainful opportunities with a stupendous growth rate of 19% during the forecast period.
  • Dairy products is another segment that will register a CAGR of 16% from 2019 to 2029.
  • Indirect distribution channels will maintain share-wide and growth-wise dominance throughout the forecast period.
  • North America and Latin America collectively account for more than half of total market value. This can be attributed to the early adopting nature of North American countries and rising millennial population in Latin America.

Consumer Preferences Shape Growth Trajectory

Increase in purchase potential and decrease in production costs is creating remunerative synergy in the market. This is fueled by advancements in packaging and labelling along with proactive consumer participation. Major players are investing in developing consumer communities that support long-term revenue generation.

The non-GMO food products industry is dependent on consumer awareness and prevalence of plant-based and vegan diets that require daily consumption of food products manufactured from non-genetically modified organisms.

Who’s Wining?

Competitive landscape in non-GMO food products industry is fragmented with the presence of multinationals, niche-manufacturers, and SMEs. Major players that shape the global non-GMO food products industry are Cargill, Inc., Associated British Foods Plc, General Mills Inc., Kraft Heinz, Archer Daniels Midland Company, Danone, Nestle S.A., The Hain Celestial Group Inc. Key players in the market are forging strategic partnerships that ensure sustained revenue prospects.

Invest in Market Research on Non-GMO Food Products Buy Now to Keep Up with Industry Trends and Competitors:
https://www.futuremarketinsights.com/checkout/11088

Market Segments Covered in Non-GMO food products Industry Analysis

By Nature :

  • Organic
  • Conventional

By Product :

  • Grain and Cereals
    • Wheat
    • Soya
    • Corn
    • Others
  • Bakery and Confectionery
    • Bread
    • Pastry
    • Candy
    • Others
  • Beverages
    • Alcoholic Beverages
    • Non-Alcoholic Beverages
  • Dairy Products
    • Yogurt
    • Cheese
    • Ice cream
    • Others
  • Infant Food
  • Condiment, Dressing, & Oil
    • Vegetable Oils
    • Jam, Jellies
    • Syrups
  • Others (Spices, soups, etc.)

By Distribution Channel :

  • Direct Sales/B2B
  • Indirect Sales/B2C
    • Supermarket/Hypermarket
    • Wholesaler
    • Online Retail
    • Specialty Stores
    • Other Retail Format

Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

All of the information is available to you! To obtain the complete report, contact one of our analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-11088

Key Questions Answered in the Report

How much is the Non-GMO food products market currently worth?

Non-GMO food products industry size is worth more than US$ 41,510 Mn.

At what CAGR is the market expected to grow?

Non-GMO food products consumption is expected to grow at a CAGR of around 13.2% during the period 2021-2031.

How was the performance in the last five years?

In terms of revenue non-GMO food products grew at a CAGR of around 10.4% during 2016-2020

What are the key trends boosting Non-GMO food product sales?

Non-GMO food products are gaining traction due to concerns over the effect of genetically modified foods on health, advanced technologies, shifting consumers’ preference towards healthy food products are the latest trends of non-GMO food products being observed in the market.

How are market players reacting to the new developments in the market?

Market companies are choosing to aim at research and development, consolidation of distribution channel in emerging countries, new product introductions to stay a noticeable player in the global market.

Which are the major countries driving demand for the Non-GMO food products Market?

The US, Russia, UK, China, Brazil, Germany, India are the major countries driving demand for non-GMO food products.

At what level does the report reflect pricing analysis?

The report presents a detailed cost analysis of non-GMO food products based on products i.e. grain and cereals, bakery & confectionery, beverages, dairy products, infant food, condiment, dressing, & oil, and others.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

 Contact Us:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Conjunctivitis Industry is On the Brink of Reaching US$ 3208.7 Million by 2032, According To a Recent FMI Report

The conjunctivitis industry, commonly known as pink eye, is an inflammation of the conjunctiva, which is the thin transparent layer that covers the white part of the eye and lines the inner surface of the eyelids. It can be caused by viruses, bacteria, allergies, or other irritants. The condition is highly contagious and can spread through direct contact or exposure to contaminated surfaces.

The conjunctivitis industry encompasses various products and treatments used to manage and treat the condition. These include over-the-counter (OTC) eye drops, prescription medications, and other therapies. Key players in the conjunctivitis industry include pharmaceutical companies, eye care product manufacturers, and healthcare providers.

Get Your Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-1318

By 2022, it is expected that the global conjunctivitis industry would have grown at a 5.8% CAGR and reached a value of US$ 1825.8 million. By 2032, the market is anticipated to reach roughly US$ 3208.7 million.

In the market for conjunctivitis treatments, factors such as prevalence, awareness, and advancements in treatment options can influence market growth. The market is driven by the high incidence of conjunctivitis worldwide and the increasing demand for effective and convenient treatment options. Additionally, factors such as growing healthcare infrastructure, rising healthcare expenditure, and increased awareness about eye health contribute to the expansion of the conjunctivitis industry.

Key Takeaways Conjunctivitis industry:

  • Prevalence: Conjunctivitis is a widespread condition, affecting people of all ages globally. It can be highly contagious, particularly in cases caused by viruses or bacteria, which can contribute to its spread within communities, schools, and workplaces.
  • Types of Conjunctivitis: There are several types of conjunctivitis, including viral conjunctivitis, bacterial conjunctivitis, allergic conjunctivitis, and chemical conjunctivitis. Each type has its own causes, symptoms, and treatment options.
  • Viral Conjunctivitis: Viral conjunctivitis is the most common form of conjunctivitis and is usually caused by adenoviruses. It can spread easily and often accompanies symptoms of respiratory infections, such as the common cold. Viral conjunctivitis is typically self-limiting and resolves on its own within a few days to a couple of weeks.
  • Bacterial Conjunctivitis: Bacterial conjunctivitis is caused by bacteria, most commonly Staphylococcus aureus, Streptococcus pneumoniae, or Haemophilus influenzae. It can be more severe and persistent than viral conjunctivitis and often requires antibiotic treatment.
  • Allergic Conjunctivitis: Allergic conjunctivitis occurs due to an allergic reaction to substances such as pollen, dust mites, pet dander, or certain medications. It can cause itching, redness, and watery discharge in the eyes. Managing allergies and avoiding allergens are crucial in treating allergic conjunctivitis.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-1318

Competitive Landscape:

The prominent players in the market are planning to invest in research and development initiatives to innovate new drugs and therapies for efficiently treating ocular disorders. The recent awareness of ocular allergies has tremendously elevated backed by numerous factors such as faster urbanization and a growing number of allergens.

Key Companies Profiled:

  • Boehringer Ingelheim GmbH
  • Allergan Inc.
  • Sanofi-Aventis
  • Atopix Therapeutics Ltd.
  • Novartis AG, Ocular Therapeutix, Inc.
  • Bausch & Lomb Inc.
  • Akorn Incorporated.
  • Auven Therapeutics
  • Sirion Therapeutics, Inc.

Key Segments of the Conjunctivitis industry:

By Type:

  • Giant Papillary Conjunctivitis
  • Seasonal Allergic Conjunctivitis
  • Vernal Keratoconjunctivitis
  • Contact Conjunctivitis
  • Perennial Conjunctivitis
  • Atopic Keratoconjunctivitis

By Treatment:

  • Mast Cell Stabilizers
  • Decongestant
  • Immunotherapy
  • Antihistamines
  • Non-steroidal Anti-Inflammatory Drugs
  • Olopatadine
  • Epinastine
  • Ointments
  • Others

For More Information, Query or Customization of this report – Visit! https://www.futuremarketinsights.com/customization-available/rep-gb-1318

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Projected Growth: Microcrystalline Cellulose Industry Sets Sights on US$ 1,794.1 Million by 2033

The global microcrystalline cellulose industry is projected to create opulent growth opportunities over the evaluation period by registering a CAGR of 6.3% from 2023 to 2033. The global market value is predicted to increase from $974.7 million in 2023 to US$ 1,794.1 million by the end of 2033.

The market’s expansion can be ascribed to rising demand in a variety of end-use industries around the world. Historically, the worldwide microcrystalline cellulose market grew at a slow CAGR of 4.9% from 2018 to 2022.

Microcrystalline cellulose (MCC) is a strong plant-derived ingredient with exceptional functional properties that perfectly suit its industrial applications as a binder, thickening agent, filler, anti-cracking agent, fat replacer, disintegrate, emulsifying agent, absorbing agent, and many others.

Request Copy of Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1017

Despite the fact that it is a typical excipient used in tablet formulations, demand from the pharmaceutical sector increased dramatically after 2020. Microcrystalline cellulose is most commonly found in the pharmaceutical and food and beverage industries. These industries are likely to account for more than half of world consumption.

MCC’s functional qualities make it an excellent fit as an ingredient in a variety of various products such as cosmetics and personal care, paints and coatings, detergents, dye absorbers, rubber, and so on. Among several end-use industries, the pharmaceutical business is expected to increase steadily in the coming years.

Report Highlights

The widespread demand for microcrystalline cellulose is anticipated to be fueled by pharmaceutical industries. MCC is used as an excipient in pharmaceutical drug formulation owing to its binding, disintegration, gliding, dilution, and carrier applications. Specifically from 2020 onwards, the demand for drugs and medicines witnessed a significant surge due to which the subsequent demand for MCC hiked from pharmaceutical drug manufacturers.

The food & beverage industry is rapidly adopting new plant-based ingredients in packaged food products. This trend will drive the consumption of microcrystalline cellulose over the next few years. Furthermore, the rising investment in developing numerous grades of microcrystalline cellulose is a key trend in recent years.

Major players within the developed market are heftily investing in innovations to capture the untapped potential applications of MCC in consumer products. Apart from this, Asia-Pacific market participants are investing in expanding their production facilities to meet the rising market demand. As a cumulative impact of these developments, the global microcrystalline cellulose market will thrive through the projection period.

Learn About Your Custom Experience: https://www.futuremarketinsights.com/customization-available/rep-gb-1017

Recent Developments

Food & beverage applications of microcrystalline cellulose have witnessed a significant demand in recent years. Traditionally, it has been utilized as a thickening and emulsifying agent, binder, filler, and anti-cracking agent in several foods such as bakery products, meats, dairy, and seafood products.

MCC is known as an excellent alternative to fats. Since, it is derived from plants, the usage of MCC in the food & beverages industry is anticipated to propel due to the growing preference for plant-based products from consumers in near future.

Besides this, several research and innovations in recent years have shown that MCC can act as a soil conditioner and agrochemical in the agricultural industry, density controller and flowability enhancer in detergents, adhesive in general industries, substitute in rubber production, and absorber in dye industries. These applications and many more are expected to facilitate opportunities for MCC in industrial applications.

Microcrystalline cellulose (MCC) is optimally derived from wood pulp which accounts for a prominent portion of the overall production of MCC. It needs plenty of tree wood obtained by cutting natural resources like forests. This process poses a lot of environmental challenges and restrictions from the governments. Hence, the wood-based production of MCC is being replaced by other natural resources like cotton crops, bamboo farming, corn, banana, and soybean crops, etc.

Don’t Miss Out – Buy Report Now: https://www.futuremarketinsights.com/checkout/1017

Key Companies Profiled

  • DuPont de Nemours, Inc
  • Asahi Kasei Corporation
  • DFE Pharma
  • J. RETTENMAIER & SÖHNE GmbH + Co KG
  • Accent Microcell Pvt. Ltd.
  • Foodchem International Corporation
  • Mingtai Chemical Co., Ltd
  • Sigachi Industries Pvt. Ltd.
  • Chemfield Cellulose
  • NB Entrepreneur
  • Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
  • Roquette Frères S.A.
  • Libraw Pharma
  • Ankit Pulps and Boards Pvt. Ltd
  • Pharmatrans Sanaq AG
  • Wei Ming Pharmaceutical Mfg Co. Ltd
  • Sixring
  • RanQ

Competitive Landscape

Prominent players operating in the global microcrystalline cellulose market acquire a crucial share of the industry. The threat of new entrants is low because of the initial capital investment in establishing the production lines.

Knowing the significant demand from end-use industries, the market players are looking to expand their production capacities along with new supply chain developments to enter into emerging markets. A few leading players also invest in research and development to introduce new applications and product grades of microcrystalline cellulose in the market.

Key Segmentation

By Material:

  • Wood based
  • Non-wood based

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia and Pacific
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube